| Bradley S Howeiler, MD | |
|
1717 S J St, Tacoma, WA 98405-4933 | |
| (253) 426-4101 | |
| (253) 426-6250 |
| Full Name | Bradley S Howeiler |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 35 Years |
| Location | 1717 S J St, Tacoma, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245271584 | NPI | - | NPPES |
| 0170810 | Other | WA | LIWA |
| HO5123 | Other | WA | BSWA TEMA |
| 8205419 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | MD00030786 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph Medical Center | Tacoma, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northwest Emergency Physicians Llc | 3476462334 | 186 |
News Archive
Republicans are preparing a spate of procedural objections to use in the event Senate Democrats try to employ budget reconciliation rules to advance their health reform proposals.
More than $9 million in federal grants will help fund researchers in the Ohio State University Davis Heart and Lung Research Institute and their collaborators across the university campus to investigate new causes and treatments for cardiovascular disease.
ePlus inc. announced today that its subsidiary, ePlus Technology inc., has achieved HP PartnerONE Healthcare Elite status. HP partners who attain Healthcare Elite status are considered experts in the healthcare environment, with superior HP-validated industry qualifications in everything from small practices to large healthcare systems.
IDC has released a new special research study on the market for employee benefits administration in the U.S., which shows that over 70% of all employers - both small and large - are either concerned or very concerned over the ramifications of potential healthcare reform legislation. While concerned with the as-yet-undetermined changes in legislation, the rising costs of providing employees with health and welfare benefits is even more of a concern to buyers, with over 80% reporting it as the top challenge they face.
Following a priority review, Health Canada has approved Lucentis (ranibizumab) as a treatment for vision loss resulting from retinal vein occlusion (RVO). This makes Lucentis the first approved treatment of its class in Canada for this debilitating condition. Patients will now have access to a treatment that is proven to be effective and has an established safety profile.
› Verified 2 days ago
| Entity Name | Northwest Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235172370 PECOS PAC ID: 3476462334 Enrollment ID: O20041214000892 |
News Archive
Republicans are preparing a spate of procedural objections to use in the event Senate Democrats try to employ budget reconciliation rules to advance their health reform proposals.
More than $9 million in federal grants will help fund researchers in the Ohio State University Davis Heart and Lung Research Institute and their collaborators across the university campus to investigate new causes and treatments for cardiovascular disease.
ePlus inc. announced today that its subsidiary, ePlus Technology inc., has achieved HP PartnerONE Healthcare Elite status. HP partners who attain Healthcare Elite status are considered experts in the healthcare environment, with superior HP-validated industry qualifications in everything from small practices to large healthcare systems.
IDC has released a new special research study on the market for employee benefits administration in the U.S., which shows that over 70% of all employers - both small and large - are either concerned or very concerned over the ramifications of potential healthcare reform legislation. While concerned with the as-yet-undetermined changes in legislation, the rising costs of providing employees with health and welfare benefits is even more of a concern to buyers, with over 80% reporting it as the top challenge they face.
Following a priority review, Health Canada has approved Lucentis (ranibizumab) as a treatment for vision loss resulting from retinal vein occlusion (RVO). This makes Lucentis the first approved treatment of its class in Canada for this debilitating condition. Patients will now have access to a treatment that is proven to be effective and has an established safety profile.
› Verified 2 days ago
| Entity Name | Northwest Observation Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023539376 PECOS PAC ID: 9032480942 Enrollment ID: O20170810000470 |
News Archive
Republicans are preparing a spate of procedural objections to use in the event Senate Democrats try to employ budget reconciliation rules to advance their health reform proposals.
More than $9 million in federal grants will help fund researchers in the Ohio State University Davis Heart and Lung Research Institute and their collaborators across the university campus to investigate new causes and treatments for cardiovascular disease.
ePlus inc. announced today that its subsidiary, ePlus Technology inc., has achieved HP PartnerONE Healthcare Elite status. HP partners who attain Healthcare Elite status are considered experts in the healthcare environment, with superior HP-validated industry qualifications in everything from small practices to large healthcare systems.
IDC has released a new special research study on the market for employee benefits administration in the U.S., which shows that over 70% of all employers - both small and large - are either concerned or very concerned over the ramifications of potential healthcare reform legislation. While concerned with the as-yet-undetermined changes in legislation, the rising costs of providing employees with health and welfare benefits is even more of a concern to buyers, with over 80% reporting it as the top challenge they face.
Following a priority review, Health Canada has approved Lucentis (ranibizumab) as a treatment for vision loss resulting from retinal vein occlusion (RVO). This makes Lucentis the first approved treatment of its class in Canada for this debilitating condition. Patients will now have access to a treatment that is proven to be effective and has an established safety profile.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bradley S Howeiler, MD 505 S 336th St, Suite 600, Federal Way, WA 98003-6328 Ph: (253) 838-6180 | Bradley S Howeiler, MD 1717 S J St, Tacoma, WA 98405-4933 Ph: (253) 426-4101 |
News Archive
Republicans are preparing a spate of procedural objections to use in the event Senate Democrats try to employ budget reconciliation rules to advance their health reform proposals.
More than $9 million in federal grants will help fund researchers in the Ohio State University Davis Heart and Lung Research Institute and their collaborators across the university campus to investigate new causes and treatments for cardiovascular disease.
ePlus inc. announced today that its subsidiary, ePlus Technology inc., has achieved HP PartnerONE Healthcare Elite status. HP partners who attain Healthcare Elite status are considered experts in the healthcare environment, with superior HP-validated industry qualifications in everything from small practices to large healthcare systems.
IDC has released a new special research study on the market for employee benefits administration in the U.S., which shows that over 70% of all employers - both small and large - are either concerned or very concerned over the ramifications of potential healthcare reform legislation. While concerned with the as-yet-undetermined changes in legislation, the rising costs of providing employees with health and welfare benefits is even more of a concern to buyers, with over 80% reporting it as the top challenge they face.
Following a priority review, Health Canada has approved Lucentis (ranibizumab) as a treatment for vision loss resulting from retinal vein occlusion (RVO). This makes Lucentis the first approved treatment of its class in Canada for this debilitating condition. Patients will now have access to a treatment that is proven to be effective and has an established safety profile.
› Verified 2 days ago
Dr. Justin Cha-cheng Ng, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 315 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-403-2050 | |
Robert F Wachtel, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 315 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-403-1000 | |
Dr. Nathan Kinneer Friedline, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 9040 Jackson Ave, Tacoma, WA 98433 Phone: 850-885-2273 | |
Barbara Sherry Mezger, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 209 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-596-3400 Fax: 253-596-3301 | |
Dr. Peter Stull, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: Madigan Army Medical Center 9040 Jackson Ave, Tacoma, WA 98431 Phone: 253-968-1250 Fax: 253-968-2550 | |
Kevin E Callahan, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 315 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-403-1000 | |
June A Burn, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 14815 Pacific Ave S, Tacoma, WA 98444 Phone: 253-697-8660 |